Gandhar Oil Refinery posts record Q1 FY27 as PAT surges 689%

The company posted a record consolidated Profit After Tax (PAT) of Rs. 206 crore in Q1 FY27

Granules India Q1 FY27 profit surges 60% as revenue climbs 22% & EBITDA jumps 37%

The company reported revenue from operations of Rs. 14,768 million in Q1FY27

Novo Nordisk takes Eli Lilly to court over Zepbound and Mounjaro advertising

New once-weekly HIV pill shows strong week-48 results: Gilead & Merck

Novartis returns to growth as blockbuster medicines drive Q2 momentum & pipeline advances

Growth was led by oncology and specialty medicines, with sales increases across several flagship products

Bausch + Lomb launches EyeGility Inserter to streamline cataract lens delivery in US

The EyeGility system is designed to provide smooth, controlled lens delivery through a 2.4mm incision

Medtronic completes $650 million SPR acquisition expanding access to non-opioid pain therapy

The deal adds SPR’s FDA-cleared SPRINT PNS System to Medtronic’s neuroscience portfolio

Kowa Pharma acquires Singapore's HST Medical

Acquisition aims to take HST Medical's heritage wellness brands to international markets while strengthening product innovation

Vimta Labs posts strong Q1 FY27 performance

Revenue climbs 13.7% YoY to Rs. 1,129 million

Galderma expands premium regenerative skincare brand Alastin across JPAC

Lupin spins out two oncology assets into Kaveri Therapeutics to accelerate global cancer drug development

New clinical-stage company to advance PRMT5 and SOS1 cancer programmes through global clinical development

Pfizer India clarifies Premarin Vaginal Cream temporarily discontinued due to supply constraints

Company tells NSE the imported menopause-care product contributes less than 1% of revenue and the disruption is not expected to materially affect financial performance

Torrent Pharma dissolves Philippines subsidiary Curatio Inc.

Company says voluntary dissolution of wholly owned subsidiary will have no material impact on business, with entity contributing nil revenue in FY26

GPCB orders closure of Aarti Drugs' Saykha amines plant over environmental non-compliances

Company says operations will continue for 15 days, corrective measures underway as it seeks revocation of closure order

USFDA issues one observation to Cipla's InvaGen plant after routine cGMP inspection

Inspection at New York manufacturing facility concludes with a single Form 483 observation; company to submit corrective response

GSK completes $10.6 billion Nuvalent acquisition expanding push into lung cancer treatments

The acquisition gives GSK access to three promising lung cancer programmes

Galmed unveils heart-targeted Aramchol in cardiac fibrosis push

TDB supports K.N. Biosciences' C-Phycocyanin technology

DST funding will help K.N. Biosciences commercialise IIT Guwahati's natural blue pigment technology, reducing import dependence and boosting India's bio-manufacturing ecosystem

NMIMS SPPSPTM and Merck India launch CATALYST program to build future pharma talent

The 12-week certification program is designed to provide students with industry-relevant knowledge through intensive modules across multiple scientific disciplines

Warburg Pincus acquires Integrace to build therapy-focused pharma platform in India

The acquisition of Integrace further strengthens the firm's healthcare investment strategy and reflects growing investor confidence in India's branded formulations market